Autek China Inc (300595) - Net Assets
Based on the latest financial reports, Autek China Inc (300595) has net assets worth CN¥5.53 Billion CNY (≈ $809.08 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥6.40 Billion ≈ $936.80 Million USD) and total liabilities (CN¥872.83 Million ≈ $127.72 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Autek China Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥5.53 Billion |
| % of Total Assets | 86.37% |
| Annual Growth Rate | 35.48% |
| 5-Year Change | 114.86% |
| 10-Year Change | 1624.73% |
| Growth Volatility | 38.79 |
Autek China Inc - Net Assets Trend (2012–2025)
This chart illustrates how Autek China Inc's net assets have evolved over time, based on quarterly financial data. See 300595 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Autek China Inc (2012–2025)
The table below shows the annual net assets of Autek China Inc from 2012 to 2025. For live valuation and market cap data, see market cap of Autek China Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.45 Billion ≈ $797.38 Million |
+5.94% |
| 2024-12-31 | CN¥5.14 Billion ≈ $752.68 Million |
+9.18% |
| 2023-12-31 | CN¥4.71 Billion ≈ $689.38 Million |
+2.51% |
| 2022-12-31 | CN¥4.60 Billion ≈ $672.46 Million |
+81.20% |
| 2021-12-31 | CN¥2.54 Billion ≈ $371.11 Million |
+27.36% |
| 2020-12-31 | CN¥1.99 Billion ≈ $291.37 Million |
+38.48% |
| 2019-12-31 | CN¥1.44 Billion ≈ $210.40 Million |
+32.83% |
| 2018-12-31 | CN¥1.08 Billion ≈ $158.39 Million |
+33.25% |
| 2017-12-31 | CN¥812.34 Million ≈ $118.87 Million |
+157.12% |
| 2016-12-31 | CN¥315.94 Million ≈ $46.23 Million |
+24.61% |
| 2015-12-31 | CN¥253.53 Million ≈ $37.10 Million |
+31.99% |
| 2014-12-31 | CN¥192.08 Million ≈ $28.11 Million |
+31.69% |
| 2013-12-31 | CN¥145.86 Million ≈ $21.34 Million |
+38.59% |
| 2012-12-31 | CN¥105.24 Million ≈ $15.40 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Autek China Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 7031.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.58 Billion | 52.49% |
| Other Components | CN¥2.33 Billion | 47.51% |
| Total Equity | CN¥4.91 Billion | 100.00% |
Autek China Inc Competitors by Market Cap
The table below lists competitors of Autek China Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Chengdu ALD Aviation Manufacturing Corp
SHE:300696
|
$1.44 Billion |
|
REX American Resources Corporation
NYSE:REX
|
$1.44 Billion |
|
Azad Engineering Limited
NSE:AZAD
|
$1.44 Billion |
|
Immunocore Holdings Ltd
NASDAQ:IMCR
|
$1.45 Billion |
|
Guangdong Yizumi Precision Machinery Co Ltd
SHE:300415
|
$1.44 Billion |
|
FMC Corporation
NYSE:FMC
|
$1.44 Billion |
|
Blackrock Municipal Target Term Closed Fund
NYSE:BTT
|
$1.44 Billion |
|
Bilia AB (publ)
ST:BILI-A
|
$1.44 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Autek China Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,697,006,548 to 4,911,934,616, a change of 214,928,068 (4.6%).
- Net income of 479,524,593 contributed positively to equity growth.
- Dividend payments of 250,874,316 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥479.52 Million | +9.76% |
| Dividends Paid | CN¥250.87 Million | -5.11% |
| Other Changes | CN¥-13.72 Million | -0.28% |
| Total Change | CN¥- | 4.58% |
Book Value vs Market Value Analysis
This analysis compares Autek China Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.01x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 66.22x to 2.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | CN¥0.17 | CN¥11.02 | x |
| 2013-12-31 | CN¥0.23 | CN¥11.02 | x |
| 2014-12-31 | CN¥0.30 | CN¥11.02 | x |
| 2015-12-31 | CN¥0.40 | CN¥11.02 | x |
| 2016-12-31 | CN¥0.49 | CN¥11.02 | x |
| 2017-12-31 | CN¥0.96 | CN¥11.02 | x |
| 2018-12-31 | CN¥1.21 | CN¥11.02 | x |
| 2019-12-31 | CN¥1.57 | CN¥11.02 | x |
| 2020-12-31 | CN¥2.06 | CN¥11.02 | x |
| 2021-12-31 | CN¥2.61 | CN¥11.02 | x |
| 2022-12-31 | CN¥4.86 | CN¥11.02 | x |
| 2023-12-31 | CN¥4.87 | CN¥11.02 | x |
| 2024-12-31 | CN¥5.24 | CN¥11.02 | x |
| 2025-12-31 | CN¥5.49 | CN¥11.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Autek China Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.76%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 25.92%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.28x
- Recent ROE (9.76%) is below the historical average (22.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 28.59% | 43.99% | 0.59x | 1.10x | CN¥19.56 Million |
| 2013 | 17.00% | 27.25% | 0.56x | 1.12x | CN¥10.21 Million |
| 2014 | 33.45% | 49.10% | 0.62x | 1.10x | CN¥44.71 Million |
| 2015 | 35.14% | 50.33% | 0.59x | 1.18x | CN¥63.46 Million |
| 2016 | 36.61% | 48.52% | 0.66x | 1.15x | CN¥82.89 Million |
| 2017 | 18.74% | 48.41% | 0.34x | 1.15x | CN¥70.36 Million |
| 2018 | 21.12% | 47.17% | 0.37x | 1.20x | CN¥113.85 Million |
| 2019 | 23.07% | 47.44% | 0.40x | 1.21x | CN¥173.85 Million |
| 2020 | 24.73% | 49.77% | 0.39x | 1.26x | CN¥258.12 Million |
| 2021 | 25.04% | 42.84% | 0.44x | 1.34x | CN¥333.15 Million |
| 2022 | 14.75% | 40.90% | 0.30x | 1.21x | CN¥200.83 Million |
| 2023 | 15.32% | 38.37% | 0.31x | 1.27x | CN¥231.46 Million |
| 2024 | 12.18% | 31.55% | 0.30x | 1.28x | CN¥102.53 Million |
| 2025 | 9.76% | 25.92% | 0.29x | 1.28x | CN¥-11.67 Million |
Industry Comparison
This section compares Autek China Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $3,100,049,038
- Average return on equity (ROE) among peers: 17.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Autek China Inc (300595) | CN¥5.53 Billion | 28.59% | 0.16x | $1.44 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.13 Billion | 7.47% | 2.10x | $467.27 Million |
| Blue Sail Medical Co Ltd (002382) | $916.68 Million | 3.17% | 0.43x | $825.68 Million |
| Andon Health Co Ltd (002432) | $20.02 Billion | 80.05% | 0.09x | $5.00 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $909.99 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $281.42 Million |
| QITIAN Technology Group Co Ltd (300061) | $471.02 Million | -17.67% | 1.36x | $722.27 Million |
| Shanghai Tofflon Science Tech (300171) | $2.95 Billion | 13.12% | 0.38x | $1.27 Billion |
| Truking Technology Ltd (300358) | $31.38 Million | 49.25% | 3.63x | $842.36 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $581.81 Million | 7.29% | 0.15x | $718.14 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $553.38 Million | 7.13% | 0.22x | $1.31 Billion |
About Autek China Inc
Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It a… Read more